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Abstract	
	
Pain	after	caesarean	section	should	be	addressed	so	that	patients	feel	comfortable	and	
can	be	mobilized	 immediately.	There	are	 two	classes	of	analgesics	 that	can	be	used	to	
reduce	pain,	namely	class	of	opioids	and	nonsteroidal	antiinflamation	drug	(NSAID).	One	
class	 of	 opioids	 frequently	 used	 is	 fentanyl,	whereas	 the	NSAID	 class	 using	 ketorolac.	
Fentanyl	is	an	opioid	analgesic	which	are	lipophilic,	so	it	has	several	advantages	compared	
to	morphine.	Ketorolac	began	to	be	widely	used	as	an	analgesic	because	of	the	nature	of	
strong	 analgesic.	 This	 study	was	 compare	 the	 use	 of	multimodal	 analgesia	 techniques	
using	 a	 continuous	 intravenous	 fentanyl‐ketorolac	 and	 ketorolac	 bolus	 intermittent.	
Subjects	 consisted	 of	 40	 post	 cesarean	 section	 were	 divided	 into	 2	 groups.	 Group	
multimodal	were	20	people	with	a	multimodal	analgesic	continuous	use,	and	20	people	
with	 intermittent	 single	 drug	 ketorolac	 as	 ketorolac	 group.	 Giving	 analgesics	 began	
shortly	after	the	surgery	is	completed.	Both	groups	were	then	seen	when	started	to	feel	
pain	using	a	visual	analog	scale	(VAS),	and	the	addition	of	analgesics	if	necessary.	Results	
showed	18	patients	(90%)	with	multimodal	analgesia	had	no	pain	since	the	completion	
of	 the	 operation	 up	 to	 24	 hours	 postoperatively	 (VAS	 0‐3),	 2	 patients	 (10%)	 need	
additional	bolus	intravenous	ketorolac	at	10	hours	postoperatively	(VAS	5).	A	total	of	20	
patients	 (100%)	with	 ketorolac	 group	 requires	 2	 times	 ketorolac	 injection	 during	 24	
hours	 postoperatively.	 This	 study	 showed	 that	 multimodal	 analgesia	 technique	 using	
fentanyl‐ketorolac	 is	 superior	 in	 reducing	 post	 cesarean	 section	 pain	 compared	 with	
single	drug	ketorolac.	
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1. Introducing	
Pain	is	an	unpleasant	feeling	that	arises	as	a	result	of	tissue	damage	or	potentially	
causing	tissue	damage.	If	acute	pain	is	not	treated	properly,	it	can	lead	to	chronic	pain,	
prolong	 hospitalization,	 thus	 increasing	 hospital	 costs,	 and	 ultimately	 reduce	 the	
satisfaction	 and	 comfort	 of	 patients	 (Garimella,	 and	 Cellini,	 2013).	 The	World	 Health	
Organization	 states	 that	 pain	 is	 a	 human	 right	 that	 should	 be	 eliminated	 or	 reduced.	
Caesarean	section	surgery	is	a	major	operation	that	causes	moderate	to	severe	pain	 in	
more	 than	 half	 of	 patients	 who	 should	 be	 treated	 carefully	 (Hadi	 and	 Hanid,	 2011).	
Postoperative	pain	caesarean	section	can	cause	patient	discomfort,	patient	mobilization	
                                                    
*	Corresponding	author.	Tel.:	+628156800919	
E‐mail	address:	ardipramono@umy.ac.id	
104 
 
process	becomes	longer,	thereby	increasing	the	risk	of	thromboembolism,	and	can	also	
affect	the	condition	of	the	mother	to	immediately	take	care	of	the	baby.		
Pain	 is	 complex	 and	 multifactorial	 phenomenon	 and	 need	 multimodal	 therapy	
(Joshi,	 2005).	 Relieving	 drugs	 commonly	 used	 are	 opioid	 (Gadsden	 ,	 et	 al,	 2005),	 or	
NSAIDs	such	as	ketorolac,	which	is	proven	to	reduce	pain	and	dose	of	opioid	if	use	singly	
(Lowder	 et	 al,	 2003).	 The	 use	 either	 faction	 opioid	 analgesics	 or	 NSAIDs,	 can	 not	
effectively	relieve	pain	without	causing	side	effects	such	as	nausea,	vomiting,	sedation,	or	
bleeding	(Jin	and	Chung,	2001).	Fentanyl	is	a	synthetic	opioid	class	that	works	by	binding	
to	 receptors	of	 the	 central	nervous	system	and	peripheral	 tissues,	 as	well	 as	have	 the	
effect	of	modulation	nociceptor.	Compared	with	morphine,	fentanyl	has	a	faster	onset	of	
action,	 is	more	 potent	 and	 has	 a	 half‐life	 faster,	 but	 has	 the	 side	 effect	 of	 respiratory	
depression,	 so	 its	 use	 is	 very	 limited	 and	 needs	 to	 be	more	 carefully	 (Garimella,	 and	
Cellini,	2013).		Ketorolac	is	a	NSAIDs	analgesic	that	can	be	injected	intravenously,	works	
by	blocking	 the	production	of	prostaglandins	by	 inhibiting	the	enzyme	cyclooxygenase	
(COX‐1)	and	can	reduce	opioid	use	between	25‐45%.	Side	effect	of	ketorolac	use	is	risk	of	
bleeding	(Oliveira	et	al,	2012).	
Some	studies	suggest	the	use	of	a	combination	of	opioid	and	NSAID	analgesic	drugs	
with	good	results,	but	have	not	found	the	optimal	combination.	Peng	dan	Sandler	(1999)	
menunjukkan	dosis	fentanyl	1‐2	ug/kgBB/jam,	sedangkan	di	rumah	sakit	Anne	Arundel	
(2011)	memakai	dosis	10	ug/jam.	In	the	case	of	post‐operative	pain,	the	addition	of	drugs	
known	as	NSAIDs	in	intravenous	morphine,	was	found	to	have	good	results	(Curatolo	and	
Sveticic,	 2002).	 Adding	 morphine	 to	 ketorolac	 has	 reduced	 the	 side	 effect	 and	 dose	
dependent	of	opioid	(Cepeda	et	al,	2005).	This	study	wanted	to	find	out	whether	the	use	
of	a	combination	of	ketorolac	and	fentanyl	 in	continuous	doses	can	reduce	pain	better	
than	single	use	of	ketorolac.	
 
2. Material	and	Method		
This	 prospective	 study	 was	 approved	 by	 the	 institutional	 ethics	 in	 teaching	
hospitals	 Faculty	 of	 Medicine	 and	 Health	 Sciences,	 Universitas	 Muhammadiyah	
Yogyakarta.	The	subject	of	this	research	is	patients	who	underwent	caesarean	section	at	
teaching	 hospital	 Asri	 Medical	 Center	 (AMC)	 and	 PKU	 Gamping	 Yogyakarta,	 and	 has	
agreed	to	participate	in	the	study.	A	total	of	40	patients	with	a	body	weight	between	40‐
70	kg,	20‐45	years	old	who	underwent	caesarean	section	with	ASA	1	and	2	status	with	
spinal	anaesthesia	since	June‐August	2016,	were	included	in	this	study.	Exclusion	criteria	
included	drug	addiction,	allergies	to	opioids	and	ketorolac,	a	history	of	bleeding,	and	the	
use	of	anticoagulant	drugs	two	weeks	before	surgery.	
Subject	were	divided	into	two	groups,	namely	the	fentanyl	and	ketorolac	group.	In	
fentanyl	group,	the	subjects	were	given	a	multimodal	analgesic	fentanyl‐ketorolac,	while	
ketorolac	group	were	given	ketorolac	intravenous	during	20	hour	after	caesarean	section	
as	they	feel	pain	(VAS	score>5).	Before	surgery,	all	subjects	received	instruction	of	the	
operation	and	the	treatment	that	will	be	given	to	treat	postoperative	caesarean	section	
pain.	All	 subjects	 received	 a	 spinal	 regional	 anaesthesia	with	 a	needle	 no.	 25,	 and	 the	
drugs	used	are	spinal	bupivacaine	12.5	mg.		
After	the	operation	is	completed,	all	subjects	were	given	a	single	dose	of	ketorolac	
30	 mg	 bolus	 intravenous,	 followed	 by	 administration	 of	 a	 combination	 of	 fentanyl	
analgesia‐ketorolac	continuously	20	hours	on	the	subject	fentanyl	group.	On	the	subject	
of	ketorolac	group,	bolus	administered	every	subject	began	to	feel	the	pain	and	the	VAS	
over	5.	All	group	were	given	ketorolac	30	mg	bolus	 intravenous	 immediately	after	 the	
operation	 ended.	 Dose	 of	 fentanyl	 group	 is	 200	 ug	 of	 fentanyl	 plus	 ketorolac	 60	mg,	
dissolved	 in	aqua	up	 to	a	volume	of	100	ml,	 than	 fill	 in	 	 syrinx	pump	(syrinxject),	and	
supplied	 continuously	 at	 a	 rate	 of	 5	 cc	 /	 hour,	while	 ketorolac	 group	 doses	 is	 30	mg	
intravenous.	Continuous	fentanyl	doses	given	10	ug	/	h,	and	continuous	dose	of	ketorolac	
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0.6	mg	/	hr.	All	groups	of	subjects	then	recorded	how	many	people	who	require	additional	
analgesic	ketorolac.	Collected	data	is	then	counted	as	percentage	number	of	subjects	who	
require	ketorolac	within	20	hours	after	surgery.	
3. Result	and	Discussion	
Forty	 subjects	 who	 participated	 in	 this	 study,	 were	 divided	 into	 20	 groups	 of	
fentanyl,	and	20	others	are	ketorolac	group.	Age	and	weight	of	the	data	presented	in	Table	
1.	In	the	group	of	fentanyl,	a	total	of	two	subjects	require	additional	ketorolac	at	the	10th	
hour	after	surgery	because	of	the	pain	by	VAS	score	of	5,	while	all	subjects	in	the	group	of	
intravenous	ketorolac	require	an	additional	two	times	for	20	hours	with	VAS	score	>5.	
(Table	2).	
	
Table	1.		Average	of	age	and	body	weight	
Group	 Age	(years)		 Body	Weight	(Kg)	
Fentanyl		 26,5	 58	
Ketorolac	 26	 57	
	
	
																																Table	2.	Amount	of	subject	who	need	additional	ketorolac	after	20	hour		
Group	 Amount	(%)	 	
Fentanyl		 2	(10%)	 	
Ketorolac	 20	(100%)	 	
	
NSAIDs	such	as	ketorolac,	works	by	blocking	the	synthesis	of	prostaglandins	by	
inhibiting	the	action	of	the	enzyme	cyclooxygenase	(COX)	type	I	and	type	II.	Decrease	in	
prostaglandin	 synthesis	 thereby	 reducing	 the	 production	 of	 chemical	 mediators	
accompanying	acute	inflammatory	response.	Several	studies	have	mentioned	that	NSAIDs	
also	decrease	response	to	pain	centers	in	the	spinal	nervous	system	(White,	2005).	Opioid	
analgesics,	 such	 as	 fentanyl,	 acts	 as	 an	 agonist	 in	 the	 peripheral	 and	 central	 opioid	
receptors.	 Although	 the	 analgesic	 property	 is	 efficient,	 it	 has	 side	 effects	 such	 as	
respiratory	depression	(Ramsay,	2000)	but	respiratory	depression	is	extremely	rare	in	
the	use	of	continuous	intravenous	(Peng	and	Sandler,	1999).	
The	results	showed	that	administration	of	a	combination	analgesic	fentanyl	and	
ketorolac	continuously	can	reduce	pain	in	the	majority	of	subject	compared	with	subject	
who	received	a	single	dose	of	ketorolac	only.	There	were	no	side	effects	of	nausea	and	
vomiting	in	both	groups.	Additional	ketorolac	in	the	ketorolac	group	and	fentanyl	group	
showed	patients	feel	pain	(VAS	score>	5).	Ding	et	al.	(1993)	suggest	that	in	patients	with	
postoperative	 gynecological,	 ketorolac	 administration	 singly	 with	 a	 dose	 of	 30	 mg	
intravenously,	could	not	reduce	early	postoperative	pain	compared	to	administration	of	
a	combination	of	ketorolac	and	fentanyl.	Etches	et	al	(1995)	demonstrated	that	ketorolac	
supplied	continuously,	can	reduce	postoperative	pain	and	reduce	the	dose	of	morphine	
given	 in	 patients	 with	 post‐operative	 hip	 and	 knee	 arthroplasty.	 In	 the	 post‐ESWL	
patients,	the	use	of	ketorolac	60	mg	iv	equally	effective	for	reducing	pain	and	fewer	side	
effects	when	compared	with	the	100	ug	fentanyl,	but	with	minimal	side	effects	(Yang	et	
al,	2002).		
	
4. Conclusion	
	
In	this	study,	administration	of	a	combination	of	fentanyl‐ketorolac	continuously	can	
reduce	 pain	 better	 than	 ketorolac	 bolus	 intravenous	 alone,	 with	 minimal	 side	 effect.	
Further	 research	 will	 be	 needed	 the	 most	 optimal	 dose	 and	 minimal	 side	 effects	 by	
administering	 a	 combination	 of	 fentanyl‐ketorolac	 continuously	 in	 patients	 post	
caesarean	section.	
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